Monthly Archives: May 2012

Roger Clemenss chief accuser told a former client that the star pitcher used performance-enhancing drugs to recuperate and push himself to the limit, according to court testimony Tuesday. A former client of Clemenss strength coach told jurors in the baseball legends perjury trial that Brian McNamee also kept syringes from injections he allegedly gave professional ballplayers to protect himself from possible prosecution. Im not going to get thrown under the bus, so Ive taken care of it, the witness, Anthony Corso, said McNamee told him. During a workout in 2002 or 2003, McNamee first told Corso that human growth hormone or HGH had helped athletes like Clemens recover. He said it was the kind of medication that would allow the athletes to continue working out as they were getting older and breaking down, Corso told jurors. McNamee mentioned that Clemens was one of the athletes he was getting positive results from. Defense attorneys had tried to block Corso, a financial consultant, from testifying about his conversations with McNamee. But U.S. District Judge Reggie Walton allowed prosecutors to question Corso Tuesday to try to back up the strength coachs testimony. McNamee is the only witness with firsthand knowledge of Clemenss alleged … Continue reading →

A mixture of drugs and alcohol impaired a Kings College boys judgement after he was told he was at risk of being expelled, a coroner has found. David Gaynor, 17, died after falling from a motorway overbridge at Greenlane in Auckland on June 11 last year. Chief Coroner Neil MacLean said toxicology reports showed David was well over the drink driving limit and had taken the Class C "party drug" 4-MEC and possibly also cannabis. After drinking at two pre-ball events, David was admitted to the ball but was later taken to a "time out" room after a security guard saw him in the female toilets. He was not known to have any mental health or anxiety issues. David and his father Brian Gaynor, who was called to collect him, were told disciplinary action would be taken at the school. Mr Gaynor said he was "upset and angry" during the trip home and that the situation was a major disappointment to him, the report said. David expressed thoughts about death, getting expelled and that he was going to jump off a bridge in subsequent texts to friends. Mr Gaynor said his own research suggested 4-MEC shouldn't be mixed with alcohol, … Continue reading →

Published: 5:27AM Wednesday May 30, 2012 Source: ONE News David Gaynor - Source: Supplied Illegal drugs and alcohol were a significant contributing factor in the death of an Auckland teenager, according to a Coroner's report. King's College student David Gaynor died from traumatic head injuries after he leapt from a motorway overbridge in central Auckland following his school ball last year. A Coroner's report into the 17-year-old's death found Gaynor knew the likely consequences of his impulsive actions when he committed suicide even though he was "clearly affected by the combination of substances he had ingested". The toxicology report found David had a blood alcohol level of 32 milligrams per 100 millilitres of blood as well as traces of two illegal drugs, party stimulant "4-MEC" and possible traces of cannabis. David had two blue pills with him at the time of the death containing the chemical 4-MEC, an amphetamine-like stimulant found in illegal party drugs such as ecstasy, which gives users a sense of short-lived euphoria. The Coroner also found David's state of mind was likely affected by the disciplinary action he was to face at school after being discovered near the female toilets at the ball "not in his … Continue reading →

NEW YORK, May 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0868600/Overview-of-the-Orphan-Diseases-and-Drugs-Space-in-Sub-Saharan-Africa.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities. Research Aim and Objectives Slide 17 Research Scope, Definitions and Exchange Rates Slide 19 Research Methodology Slide 23 Orphan Drugs and Diseases in Sub-Saharan AfricaAn Introduction Slide 25 Definition of an Orphan Disease Slide 26 Neglected Tropical DiseasesAn Overview Slide 27 Rare DiseasesAn Overview Slide 28 More here: Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa … Continue reading →